Duragesic-50 and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Duragesic-50 (fentanyl) and Lantus (insulin glargine recombinant). Common drug interactions include cellulitis among females and depression among males.

The phase IV clinical study analyzes what interactions people have when they take Duragesic-50 and Lantus. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Duragesic-50?

Duragesic-50 has active ingredients of fentanyl. It is often used in pain. eHealthMe is studying from 733 Duragesic-50 users. Check the latest studies of Duragesic-50.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

On Jul, 14, 2026

15 people who take Duragesic-50 and Lantus together, and have interactions are studied.

Duragesic-50 and Lantus drug interactions.

What are the common drug interactions of Duragesic-50 and Lantus, by gender? *:

female:

Cellulitis (infection under the skin)
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Conjunctival haemorrhage (bleeding underneath the conjunctiva)
Constipation
Cough
Deafness
Decreased appetite
Dental caries
Depression
Diabetes mellitus inadequate control

male:

Depression
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Dysuria (painful or difficult urination)
Emotional distress
Exostosis (formation of new bone on the surface of a bone)
Failure to thrive (inadequate weight gain and physical growth in children)
Haematochezia (passage of stools containing blood)
Hypophagia (reduced food intake)
Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
Injury

What are the common drug interactions of Duragesic-50 and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blindness
Hyperhidrosis (abnormally increased sweating)
Muscle spasms (muscle contraction)
Neuralgia (pain in one or more nerves)
Swelling
Weight fluctuation

50-59:

Dyspepsia (indigestion)
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
Eyelid oedema (eyelids are swollen and contain excessive fluid)
Fall
Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
Flushing (the warm, red condition of human skin)
Fungal infection
Gingival erythema (redness of gums)

60+:

Renal impairment (severely reduced kidney function)
Blood calcium decreased
Constipation
Fall
Hallucination (an experience involving the perception of something not present)
Hip fracture
Hypokalaemia (low potassium)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Vomiting
White blood cell count decreased

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 4 people, 26.67%
Nuclear Magnetic Resonance Imaging Brain: 3 people, 20.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 20.00%
Anaemia (lack of blood): 3 people, 20.00%
Skin Ulcer: 2 people, 13.33%
Osteoporosis (bones weak and more likely to break): 2 people, 13.33%
Renal Cell Carcinoma (a kidney cancer): 1 person, 6.67%
Phantom Pain: 1 person, 6.67%
Neuropathy Peripheral (surface nerve damage): 1 person, 6.67%
Joint Pain: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Duragesic-50 and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously